These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
443 related items for PubMed ID: 9711940
1. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T. Circulation; 1998 Jul 28; 98(4):346-52. PubMed ID: 9711940 [Abstract] [Full Text] [Related]
2. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T. Circulation; 1996 Nov 15; 94(10):2626-32. PubMed ID: 8921810 [Abstract] [Full Text] [Related]
3. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K, Kishimoto T. J Clin Invest; 1997 Jun 15; 99(12):2898-905. PubMed ID: 9185513 [Abstract] [Full Text] [Related]
4. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. Tone E, Kunisada K, Kumanogoh A, Negoro S, Funamoto M, Osugi T, Kishimoto T, Yamauchi-Takihara K. Cytokine; 2000 Oct 15; 12(10):1512-8. PubMed ID: 11023666 [Abstract] [Full Text] [Related]
6. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. Funamoto M, Fujio Y, Kunisada K, Negoro S, Tone E, Osugi T, Hirota H, Izumi M, Yoshizaki K, Walsh K, Kishimoto T, Yamauchi-Takihara K. J Biol Chem; 2000 Apr 07; 275(14):10561-6. PubMed ID: 10744750 [Abstract] [Full Text] [Related]
9. A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. Ng DC, Long CS, Bogoyevitch MA. J Biol Chem; 2001 Aug 03; 276(31):29490-8. PubMed ID: 11382751 [Abstract] [Full Text] [Related]
10. Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes. Tone E, Kunisada K, Fujio Y, Matsui H, Negoro S, Oh H, Kishimoto T, Yamauchi-Takihara K. Biochem Biophys Res Commun; 1998 Dec 09; 253(1):147-50. PubMed ID: 9875235 [Abstract] [Full Text] [Related]
11. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Kodama H, Fukuda K, Pan J, Makino S, Baba A, Hori S, Ogawa S. Circ Res; 1997 Nov 09; 81(5):656-63. PubMed ID: 9351438 [Abstract] [Full Text] [Related]
12. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T, Akira S. Proc Natl Acad Sci U S A; 1996 Apr 30; 93(9):3963-6. PubMed ID: 8632998 [Abstract] [Full Text] [Related]
13. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H. Circulation; 2003 Feb 18; 107(6):798-802. PubMed ID: 12591746 [Abstract] [Full Text] [Related]
14. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. Ernst M, Inglese M, Waring P, Campbell IK, Bao S, Clay FJ, Alexander WS, Wicks IP, Tarlinton DM, Novak U, Heath JK, Dunn AR. J Exp Med; 2001 Jul 16; 194(2):189-203. PubMed ID: 11457894 [Abstract] [Full Text] [Related]
15. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? Sriram K, Benkovic SA, Hebert MA, Miller DB, O'Callaghan JP. J Biol Chem; 2004 May 07; 279(19):19936-47. PubMed ID: 14996842 [Abstract] [Full Text] [Related]
16. Leukemia inhibitory factor induces a hypertrophic response mediated by gp130 in murine cardiac myocytes. Matsui H, Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K. Res Commun Mol Pathol Pharmacol; 1996 Aug 07; 93(2):149-62. PubMed ID: 8884986 [Abstract] [Full Text] [Related]
17. Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts. Hiragun T, Morita E, Mihara S, Tanaka T, Gyotoku E, Kameyoshi Y, Yamamoto S. FEBS Lett; 2000 Dec 29; 487(2):219-23. PubMed ID: 11150513 [Abstract] [Full Text] [Related]
18. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling. Jenkins BJ, Quilici C, Roberts AW, Grail D, Dunn AR, Ernst M. Exp Hematol; 2002 Nov 29; 30(11):1248-56. PubMed ID: 12423677 [Abstract] [Full Text] [Related]
19. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Kim H, Baumann H. Mol Cell Biol; 1999 Aug 29; 19(8):5326-38. PubMed ID: 10409724 [Abstract] [Full Text] [Related]
20. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets. Majka M, Ratajczak J, Villaire G, Kubiczek K, Marquez LA, Janowska-Wieczorek A, Ratajczak MZ. Exp Hematol; 2002 Jul 29; 30(7):751-60. PubMed ID: 12135673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]